Progenitor/stem cell markers in brain adjacent to glioblastoma: GD3 ganglioside and NG2 proteoglycan expression

Journal of Neuropathology and Experimental Neurology

Volumn 75, Issue 2, 2016, Pages 134-147

  Lama, Gina ^a   Mangiola, Annunziato ^a   Proietti, Gabriella ^a   Colabianchi, Anna ^a   Angelucci, Cristiana ^a   D'Alessio, Alessio ^a   De Bonis, Pasquale ^b   Geloso, Maria Concetta ^a   Lauriola, Libero ^a   Binda, Elena ^c   Biamonte, Filippo ^a   Giuffrida, Maria Grazia ^c   Vescovi, Angelo ^c,d   Sica, Gigliola ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Brain adjacent to tumor; Cancer stem cells; GD3 ganglioside; Glioblastoma; NG2 proteoglycan

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; GANGLIOSIDE GD3; MESSENGER RNA; NESTIN; PROTEOGLYCAN; PROTEOGLYCAN NG2; UNCLASSIFIED DRUG; ACTA2 PROTEIN, HUMAN; ACTIN; ALPHA-N-ACETYLNEURAMINATE ALPHA-2,8-SIALYLTRANSFERASE; ANTIGEN; CHONDROITIN SULFATE PROTEOGLYCAN 4; GANGLIOSIDE; GANGLIOSIDE, GD3; NES PROTEIN, HUMAN; SIALYLTRANSFERASE; TUMOR MARKER;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL ISOLATION; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; ANIMAL; BIOSYNTHESIS; BRAIN CHEMISTRY; BRAIN TUMOR; GENETICS; KARNOFSKY PERFORMANCE STATUS; METABOLISM; SCID MOUSE; STEM CELL; YOUNG ADULT;

ACTINS; ADULT; AGED; ANIMALS; ANTIGENS; BIOMARKERS, TUMOR; BRAIN CHEMISTRY; BRAIN NEOPLASMS; FEMALE; GANGLIOSIDES; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; MALE; MICE; MICE, SCID; MIDDLE AGED; NESTIN; PROTEOGLYCANS; SIALYLTRANSFERASES; STEM CELLS; YOUNG ADULT;

EID: 84960324161     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1093/jnen/nlv012     Document Type: Article

References (52)

1. Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008;321:1808-12
2. McDonald KL, Aw G, Kleihues P. Role of biomarkers in the clinical management of glioblastomas: What are the barriers and how can we overcome them? Front Neurol 2012;3:1-8
3. Furnari FB, Fenton T, Bachoo RM, et al. Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes Dev 2007;212:683-710
4. Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 1980;30:907-11
5. Park I, Tamai G, Lee MC, et al. Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings. Int J Radiat Oncol Biol Phys 2007;69:381-9
6. Bakshi A, Nag TC, Wadhwa S, et al. The expression of nitric oxide synthases in human brain tumours and peritumoral areas. J Neurol Sci 1998;155:196-203
7. Roy S, Sarkar C. Ultrastuctural study of micro-blood vessels in human brain tumors and peritumoral tissue. J Neurooncol 1989;7:283-94
8. Lorger M. Tumormicroenvironment in the brain. Cancers 2012;4:218-43
9. Charles NA, Holland EC, Gilbertson R, et al. The brain tumor microenvironment. Glia 2012;60:502-14
10. Dehnhardt M, Zoriy MV, Khan Z, et al. Element distribution is altered in a zone surrounding human glioblastoma multiforme. J Trace Elem Med Biol 2008;22:17-23
11. Melani A, De Micheli E, Pinna G, et al. Adenosine extracellular levels in human brain gliomas: An intraoperative microdialysis study. Neurosci Lett 2003;346:93-6
12. Cubillos S, Obregón F, Vargas MF, et al. Taurine concentration in human gliomas and meningiomas: Tumoral, peritumoral, and extratumoral tissue. Adv Exp Med Biol 2006;583:419-22
13. Haybaeck J, Obrist P, Schindler CU, et al. STAT-1 expression in human glioblastoma and peritumoral tissue. Anticancer Res 2007;27: 3829-35
14. Lama G, Mangiola A, Anile C, et al. Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissue. Int J Oncol 2007; 30:1333-42
15. Mangiola A, Lama G, Giannitelli C, et al. Stem cell marker nestin and c- Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: Possible prognostic implications. Clin Cancer Res 2007; 13:6970-7
16. Ehrmann J, Kolár Z, Mokry J. Nestin as a diagnostic and prognostic marker: Immunohistochemical analysis of its expression in different tumours. J Clin Pathol 2005;58:222-3
17. Lendahl U1, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell 1990;60:585-95
18. Dallas NA, Samuel S, Xia L, et al. Endoglin (CD105): A marker of tumor vasculature and potential target for therapy. Clin Cancer Res 2008; 14:1931-7
19. Sica G, Lama G, Anile C, et al. Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma. Int J Oncol 2011;38:41-9
20. Mangiola A, Saulnier N, De Bonis P, et al. Gene expression profile of glioblastoma peritumoral tissue: An ex vivo study. PLoS One 2013;8: e57145
21. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004;432:396-401
22. Piccirillo SG, Combi R, Cajola L, et al. Distinct pools of cancer stemlike cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution. Oncogene 2009;28: 1807-11
23. Al-Mayhani MT, Grenfell R, Narita M, et al. NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature. Neuro Oncol 2011;13:830-45
24. Merzak A, Koochekpour S, Pilkington GJ. Adhesion of human glioma cell lines to fibronectin, laminin, vitronectin and collagen I is modulated by gangliosides in vitro. Cell Adhes Commun 1995;3:27-43
25. Koochekpour S, Merzak A, Pilkington GJ. Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro. Cancer Lett 1996;19:209-15
26. Koochekpour S, Pilkington GJ. Vascular and perivascular GD3 expression in human glioma. Cancer Lett 1996;104:97-102
27. Chow LM, Baker SJ. PTEN function in normal and neoplastic growth. Cancer Lett 2006;241:184-96
28. Zhao Y, Yu H, Hu W. The regulation of MDM2 oncogene and its impact on human cancers. Acta Biochim Biophys Sin 2014;46:180-9
29. Mangiola A, De Bonis P, Maira G, et al. Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme. Cancer 2008;113:841-6
30. Hoelzinger DB, Mariani L, Weis J, et al. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 2005;7:7-16
31. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-96
32. Binda E, Visioli A, Giani F, et al. The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas. Cancer Cell 2012;22:765-80
33. Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004;64:7011-21
34. Bernardini L, Giuffrida MG, Francalanci P, et al. X chromosome monosomy restricted to the left ventricle is not a major cause of isolated hypoplastic left heart. Am J Med Genet A 2010;152A:1967-72
35. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 22DDCT method. Methods 2001;25:402-8
36. Chekenya M, Enger PØ, Thorsen F, et al. The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours. Neuropathol Appl Neurobiol 2002; 28:367-80
37. Kawai K,Watarai S, Takahashi H, et al. Demonstration of ganglioside GD3 in human reactive astrocytes. Psychiatry Clin Neurosci 1999;53:79-82
38. Goldman JE, Reynolds R. A reappraisal of ganglioside GD3 expression in the CNS. Glia 1996;16:291-5
39. Stallcup WB, Huang FJ. A role for the NG2 proteoglycan in glioma progression. Cell Adhes Migr 2008;2:192-201
40. Zhu L, Lu J, Tay SS, et al. Induced NG2 expressing microglia in the facial motor nucleus after facial nerve axotomy. Neuroscience 2010;166:842-51
41. Assanah M, Lochhead R, Ogden A, et al. Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J Neurosci 2006;26:6781-90
42. Ohkawa Y, Momota H, Kato A, et al. Ganglioside GD3 enhances invasiveness of gliomas by forming a complex with platelet-derived growth factor receptor a and Yes kinase. J Biol Chem 2015;290:16043-58
43. Jung JU, Ko K, Lee DH, et al. The roles of glycosphingolipids in the proliferation and neural differentiation of mouse embryonic stem cells. Exp Mol Med 2009;41:935-45
44. Alessandri G, Raju KS, Cullino PM. Interaction of gangliosides with fibronectin in the mobilization of capillary endothelium. Possible influence on metastasis. Invasion Metastasis 1986;6:145-65
45. Birnbaum T, Hildebrandt J, Nuebling G, et al. Glioblastoma-dependent differentiation and angiogenic potential of human mesenchymal stem cells in vitro. J Neurooncol 2011;105:57-65
46. Birnbaum T, Roider J, Schankin CJ, et al. Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. J Neurooncol 2007;83:241-7
47. Birbrair A, Zhang T, Wang ZM, et al. Type-2 pericytes participate in normal and tumoral angiogenesis. Am J Physiol Cell Physiol 2014;307:C25-38
48. Cheng L, Huang Z, Zhou W, et al. Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell 2013; 28:139-52
49. Chamberlain G, Fox J, Ashton B, et al. Concise review: Mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells J 2007;25:2739-49
50. Piccirillo SG, Dietz S, Madhu B, et al. Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin. Br J Cancer 2012;107:462-8
51. Glas M, Rath BH, Simon M, et al. Residual tumor cells are unique cellular targets in glioblastoma. Ann Neurol 2010;68:264-9
52. Wang J, Svendsen A, Kmiecik J, et al. Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma. PLoS One 2011;6:e23062